메뉴 건너뛰기




Volumn 93, Issue SUPPL. 1, 2011, Pages

Insulin analogs versus human insulin in type 2 diabetes

Author keywords

Diabetes mellitus type 2; Human insulin; Insulin analogs; Insulin therapy

Indexed keywords

BIPHASIC INSULIN; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE;

EID: 84860408576     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70023-7     Document Type: Article
Times cited : (12)

References (15)
  • 1
    • 38049066236 scopus 로고    scopus 로고
    • Insulin regimens for type 2 diabetes mellitus
    • Brunton S Insulin regimens for type 2 diabetes mellitus. J Fam Pract 2006, 55:10S-107.
    • (2006) J Fam Pract , vol.55
    • Brunton, S.1
  • 3
    • 33845965337 scopus 로고    scopus 로고
    • Intermediate and long-acting insulin: a review of NPH insulin, insulin glargine and insulin detemir
    • Peterson GE Intermediate and long-acting insulin: a review of NPH insulin, insulin glargine and insulin detemir. Curr Med Res Opin 2006, 22:2613-2619.
    • (2006) Curr Med Res Opin , vol.22 , pp. 2613-2619
    • Peterson, G.E.1
  • 4
    • 33845236398 scopus 로고    scopus 로고
    • Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
    • Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006, 28:1569-1581.
    • (2006) Clin Ther , vol.28 , pp. 1569-1581
    • Philis-Tsimikas, A.1    Charpentier, G.2    Clauson, P.3    Ravn, G.M.4    Roberts, V.L.5    Thorsteinsson, B.6
  • 5
    • 50049118914 scopus 로고    scopus 로고
    • Long-acting insulin analogs versus human insulins
    • Garg SK, Naik RG Long-acting insulin analogs versus human insulins. Diabetes Techn Ther 2008, 10:331-332.
    • (2008) Diabetes Techn Ther , vol.10 , pp. 331-332
    • Garg, S.K.1    Naik, R.G.2
  • 6
    • 0242269000 scopus 로고    scopus 로고
    • The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    • Riddle MC, Rosenstock J, Gerich J The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003, 26:3080-3086.
    • (2003) Diabetes Care , vol.26 , pp. 3080-3086
    • Riddle, M.C.1    Rosenstock, J.2    Gerich, J.3
  • 7
    • 33746391488 scopus 로고    scopus 로고
    • A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy as oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes
    • Hermansen K, Davies M, Derezinski T, Ravn GM, Clauson P, Home P A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy as oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetes Care 2006, 29:1269-1274.
    • (2006) Diabetes Care , vol.29 , pp. 1269-1274
    • Hermansen, K.1    Davies, M.2    Derezinski, T.3    Ravn, G.M.4    Clauson, P.5    Home, P.6
  • 8
    • 39049105019 scopus 로고    scopus 로고
    • A randomised 52 week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes
    • Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G A randomised 52 week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetologia 2008, 51:408-416.
    • (2008) Diabetologia , vol.51 , pp. 408-416
    • Rosenstock, J.1    Davies, M.2    Home, P.D.3    Larsen, J.4    Koenen, C.5    Schernthaner, G.6
  • 9
    • 15944382350 scopus 로고    scopus 로고
    • Reduced hypoglycaemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    • Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A Reduced hypoglycaemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005, 28:950-955.
    • (2005) Diabetes Care , vol.28 , pp. 950-955
    • Rosenstock, J.1    Dailey, G.2    Massi-Benedetti, M.3    Fritsche, A.4    Lin, Z.5    Salzman, A.6
  • 11
    • 47649100195 scopus 로고    scopus 로고
    • Long-acting insulin analogues versus NPH human insulin in type 2 diabetes. A meta-analysis
    • Monami M, Marchionni N, Mannucci E Long-acting insulin analogues versus NPH human insulin in type 2 diabetes. A meta-analysis. Diabetes Res Clin Pract 2008, 81:184-189.
    • (2008) Diabetes Res Clin Pract , vol.81 , pp. 184-189
    • Monami, M.1    Marchionni, N.2    Mannucci, E.3
  • 12
    • 22144484165 scopus 로고    scopus 로고
    • Systemic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus
    • Plank J, Siebenhofer A, Berghold A, Jeitler K, Horvath K, Mrak P, et al. Systemic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med 2005, 165:1337-1344.
    • (2005) Arch Intern Med , vol.165 , pp. 1337-1344
    • Plank, J.1    Siebenhofer, A.2    Berghold, A.3    Jeitler, K.4    Horvath, K.5    Mrak, P.6
  • 13
    • 34249807045 scopus 로고    scopus 로고
    • When basal insulin therapy in type 2 diabetes mellitus is not enough -what next?
    • Raccah D, Bretzel RG, Owens D, Riddle M When basal insulin therapy in type 2 diabetes mellitus is not enough -what next?. Diabetes Metab Res Rev 2007, 23:257-264.
    • (2007) Diabetes Metab Res Rev , vol.23 , pp. 257-264
    • Raccah, D.1    Bretzel, R.G.2    Owens, D.3    Riddle, M.4
  • 14
    • 62549083402 scopus 로고    scopus 로고
    • Safety and effectiveness of biphasic insulin aspart 30/70 (NOVOMIX 30) when switching from human penmix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE(tm) observational study
    • Shah S, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, et al. Safety and effectiveness of biphasic insulin aspart 30/70 (NOVOMIX 30) when switching from human penmix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE(tm) observational study. Int J Clin Pract 2009, 63:574-582.
    • (2009) Int J Clin Pract , vol.63 , pp. 574-582
    • Shah, S.1    Benroubi, M.2    Borzi, V.3    Gumprecht, J.4    Kawamori, R.5    Shaban, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.